Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-Current Debt (2016 - 2018)

Tandem Diabetes Care's Non-Current Debt history spans 6 years, with the latest figure at $77.1 million for Q2 2018.

  • For Q2 2018, Non-Current Debt rose 3.24% year-over-year to $77.1 million; the TTM value through Jun 2018 reached $77.1 million, up 3.24%, while the annual FY2017 figure was $76.5 million, 3.06% down from the prior year.
  • Non-Current Debt reached $77.1 million in Q2 2018 per TNDM's latest filing, up from $76.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $79.0 million in Q4 2016 to a low of $29.3 million in Q4 2015.
  • Average Non-Current Debt over 5 years is $54.2 million, with a median of $44.7 million recorded in 2016.
  • Peak YoY movement for Non-Current Debt: soared 169.72% in 2016, then fell 3.06% in 2017.
  • A 5-year view of Non-Current Debt shows it stood at $29.4 million in 2014, then dropped by 0.56% to $29.3 million in 2015, then skyrocketed by 169.72% to $79.0 million in 2016, then fell by 3.06% to $76.5 million in 2017, then increased by 0.73% to $77.1 million in 2018.
  • Per Business Quant, the three most recent readings for TNDM's Non-Current Debt are $77.1 million (Q2 2018), $76.4 million (Q1 2018), and $76.5 million (Q4 2017).